Shakaib Razzaq, MD
General Practice · Milwaukee, WINPI 1497712574
Payments from drug & device makers
Across 93 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$508
- AbbVie$318
- Daiichi Sankyo Inc.$143
- Novo Nordisk$99
- Lilly USA, LLC$94
- Bayer$67
- plus $683 from 21 others
What the payments were for
- Food & beverage$1,914100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 17 | $508 |
| AbbVie | 17 | $318 |
| Daiichi Sankyo Inc. | 6 | $143 |
| Novo Nordisk | 6 | $99 |
| Lilly USA, LLC | 5 | $94 |
| Bayer | 3 | $67 |
| Dexcom, Inc. | 3 | $66 |
| Phathom Pharmaceuticals, Inc. | 6 | $63 |
| Amgen | 3 | $63 |
| Xeris Pharmaceuticals, Inc. | 3 | $61 |
| Lundbeck LLC | 2 | $46 |
| Ardelyx, Inc. | 3 | $44 |
| Exact Sciences | 2 | $40 |
| Nestle Healthcare Nutrition Inc. | 2 | $34 |
| ANI Pharmaceuticals, Inc. | 1 | $30 |
| Genentech USA, Inc. | 1 | $28 |
| Eisai Inc. | 1 | $27 |
| Pfizer | 2 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Grifols USA, LLC | 1 | $19 |
| Cranial Technologies, Inc | 1 | $17 |
| QOL Medical, LLC | 1 | $16 |
| Merck | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Therapeuticsmd, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$125
How this compares
$1,914 in reported general payments places this provider in the 90th percentile of 1,554 general practice providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 65 | $48,620 |
| FarxigaDapagliflozin Propanediol | 44 | $43,857 |
| OzempicSemaglutide | 37 | $35,946 |
| EliquisApixaban | 48 | $32,117 |
| JanumetSitagliptin Phos/Metformin Hcl | 32 | $31,688 |
| JardianceEmpagliflozin | 40 | $30,055 |
| TrulicityDulaglutide | 27 | $28,360 |
| TradjentaLinagliptin | 22 | $24,673 |
| Spiriva HandihalerTiotropium Bromide | 35 | $22,366 |
| MyrbetriqMirabegron | 29 | $22,110 |
| JanuviaSitagliptin Phosphate | 19 | $10,243 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $10,006 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $9,233 |
| SymbicortBudesonide/Formoterol Fumarate | 35 | $8,251 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 44 | $6,368 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $508 | $62,11395 claims |
| AbbVieLinzess | $318 | $48,62065 claims |
| MerckJanumet, Januvia | $13 | $41,93151 claims |
| Novo NordiskOzempic | $99 | $35,94637 claims |
| PfizerEliquis | $27 | $32,11748 claims |
| Lilly USA, LLCTrulicity | $94 | $28,36027 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,554 general practice providers in Wisconsin.
Other general practice in Milwaukee
- Amanda ReiswigMilwaukee$46K
- Richard KaplanMilwaukee$13K
- Likesha Arif-HolmesMilwaukee$5K
- Richard WinterMilwaukee$3K
- Michael RomeneskoAppleton$457K
- Brian JenkinsNeenah$180K
- Michael SzymanskiMenomonee Falls$71K
- Jessica KeldermanMadison$59K
- James AmstadtSun Prairie$49K
- Mary EldridgeKenosha$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.